AEGIR — Aegirbio AB Share Price
Last Trade - 00:00- SEK4.37bn
- SEK4.36bn
- SEK0.01m
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End 31st Dec | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Aegirbio AB is a Sweden-based diagnostic company that offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. The company's tests for optimized dosage of biological drugs focused on diseases in neurology, autoimmune diseases and cancer.
Directors
- Last Annual
- December 31st, 2020
- Last Interim
- March 31st, 2021
- Incorporated
- January 1st, 1970
- Public Since
- January 1st, 1970
- No. of Employees
- 1
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 13,110,913
- Address
- c/o IDEON SCIENCE PARK, Solvegatan 43, LUND, 223 70
- Web
- https://aegirbio.com/
- Phone
- Auditors
- KPMG AB
Latest News for AEGIR
Upcoming events for AEGIR
Similar to AEGIR
BIOSERVO TECHNOLOGIES ORD
OMX Nordic Exchange Stockholm
BOULE DIAGNOSTICS ORD
OMX Nordic Exchange Stockholm
CELLINK ORD
OMX Nordic Exchange Stockholm
C-RAD ORD
OMX Nordic Exchange Stockholm
ELEKTA ORD
OMX Nordic Exchange Stockholm
FAQ
As of Today at 19:56 UTC, shares in Aegirbio AB are trading at SEK333.00. This share price information is delayed by 15 minutes.
Shares in Aegirbio AB last closed at SEK333.00 and the price had moved by +870.85% over the past 365 days. In terms of relative price strength the Aegirbio AB share price has outperformed the FTSE Global All Cap Index by +653.81% over the past year.
There is no consensus recommendation for this security.
Aegirbio AB does not currently pay a dividend.
Aegirbio AB does not currently pay a dividend.
Aegirbio AB does not currently pay a dividend.
To buy shares in Aegirbio AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK333.00, shares in Aegirbio AB had a market capitalisation of SEK4.37bn.
Here are the trading details for Aegirbio AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: AEGIR
Shares are classified based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Aegirbio AB does not currently have a style classification.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aegirbio AB. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +1041.51%.
As of the last closing price of SEK333.00, shares in Aegirbio AB were trading +283.93% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We are not able to find PE ratio data for Aegirbio AB.
We do not have data on Aegirbio AB's directors
We do not have data on Aegirbio AB's shareholders